Guminski A, Foley P, Grob J-J, Robert C, Gutzmer R, Squittieri N, Kiecker F. Biochemistry laboratory shift based on common terminology criteria in patients with advanced basal cell carcinoma receiving sonidegib 200 mg daily: Results from the 42-month BOLT study. J of Skin [Internet]. 2023 Mar. 13 [cited 2024 Jul. 4];7(2):s181. Available from: https://jofskin.org/33014/index.php/skin/article/view/2013